Zhang F, Qiu H, Dong X, Zhang X, Wang C, Li X
Life Med. 2025; 1(2):179-195.
PMID: 39871934
PMC: 11748996.
DOI: 10.1093/lifemedi/lnac002.
Ewoldt J, DePalma S, Jewett M, Karakan M, Lin Y, Mir Hashemian P
Nat Methods. 2024; 22(1):24-40.
PMID: 39516564
DOI: 10.1038/s41592-024-02480-7.
Du X, Jia H, Chang Y, Zhao Y, Song J
Bioact Mater. 2024; 40:88-103.
PMID: 38962658
PMC: 11220467.
DOI: 10.1016/j.bioactmat.2024.05.043.
Lee S, Rhee J, Seok J, Kim J, Kim M, Song G
Stem Cells Transl Med. 2024; 13(8):750-762.
PMID: 38946019
PMC: 11328931.
DOI: 10.1093/stcltm/szae029.
Adkins-Threats M, Arimura S, Huang Y, Divenko M, To S, Mao H
Cell Stem Cell. 2024; 31(6):886-903.e8.
PMID: 38733994
PMC: 11162331.
DOI: 10.1016/j.stem.2024.04.016.
Molecular docking and molecular dynamics simulation decoding molecular mechanism of EDCs binding to hERRγ.
Sun Y, Chen L, Zhao B, Wang R
J Mol Model. 2024; 30(5):127.
PMID: 38594491
DOI: 10.1007/s00894-024-05926-z.
Thiamine-modified metabolic reprogramming of human pluripotent stem cell-derived cardiomyocyte under space microgravity.
Han X, Qu L, Yu M, Ye L, Shi L, Ye G
Signal Transduct Target Ther. 2024; 9(1):86.
PMID: 38584163
PMC: 10999445.
DOI: 10.1038/s41392-024-01791-7.
Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications.
Min S, Kim S, Sim W, Choi Y, Joo H, Park J
Nat Commun. 2024; 15(1):2564.
PMID: 38519491
PMC: 10960018.
DOI: 10.1038/s41467-024-46928-y.
iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity.
Lee T, Coles J, Maynes J
Front Pharmacol. 2024; 15:1308217.
PMID: 38482053
PMC: 10933010.
DOI: 10.3389/fphar.2024.1308217.
CD151 expression marks atrial- and ventricular- differentiation from human induced pluripotent stem cells.
Nakanishi-Koakutsu M, Miki K, Naka Y, Sasaki M, Wakimizu T, Napier S
Commun Biol. 2024; 7(1):231.
PMID: 38418926
PMC: 10901864.
DOI: 10.1038/s42003-024-05809-2.
Human induced pluripotent stem cell-derived closed-loop cardiac tissue for drug assessment.
Li J, Hua Y, Liu Y, Qu X, Zhang J, Ishida M
iScience. 2024; 27(2):108992.
PMID: 38333703
PMC: 10850789.
DOI: 10.1016/j.isci.2024.108992.
Histone demethylase KDM5 regulates cardiomyocyte maturation by promoting fatty acid oxidation, oxidative phosphorylation, and myofibrillar organization.
Deogharia M, Venegas-Zamora L, Agrawal A, Shi M, Jain A, McHugh K
Cardiovasc Res. 2024; 120(6):630-643.
PMID: 38230606
PMC: 11074792.
DOI: 10.1093/cvr/cvae014.
Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.
Hasegawa M, Miki K, Kawamura T, Takei Sasozaki I, Higashiyama Y, Tsuchida M
Dev Growth Differ. 2024; 66(2):119-132.
PMID: 38193576
PMC: 11457505.
DOI: 10.1111/dgd.12909.
Cardiac maturation.
Sakamoto T, Kelly D
J Mol Cell Cardiol. 2023; 187:38-50.
PMID: 38160640
PMC: 10923079.
DOI: 10.1016/j.yjmcc.2023.12.008.
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
Xu W, Billon C, Li H, Wilderman A, Qi L, Graves A
Circulation. 2023; 149(3):227-250.
PMID: 37961903
PMC: 10842599.
DOI: 10.1161/CIRCULATIONAHA.123.066542.
DIAPH1-MFN2 interaction regulates mitochondria-SR/ER contact and modulates ischemic/hypoxic stress.
Yepuri G, Ramirez L, Theophall G, Reverdatto S, Quadri N, Hasan S
Nat Commun. 2023; 14(1):6900.
PMID: 37903764
PMC: 10616211.
DOI: 10.1038/s41467-023-42521-x.
ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation.
Fujiwara Y, Miki K, Deguchi K, Naka Y, Sasaki M, Sakoda A
Stem Cell Reports. 2023; 18(11):2108-2122.
PMID: 37802074
PMC: 10679535.
DOI: 10.1016/j.stemcr.2023.09.003.
Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathophysiology.
Fan X, Yang G, Duru F, Grilli M, Akin I, Zhou X
Stem Cell Rev Rep. 2023; 19(8):2683-2708.
PMID: 37731079
PMC: 10661732.
DOI: 10.1007/s12015-023-10615-0.
Deciphering mechanisms of cardiomyocytes and non-cardiomyocyte transformation in myocardial remodeling of permanent atrial fibrillation.
Sheng Y, Wang Y, Chang Y, Ye D, Wu L, Kang H
J Adv Res. 2023; 61:101-117.
PMID: 37722560
PMC: 11258668.
DOI: 10.1016/j.jare.2023.09.012.
Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
Yang H, Yang Y, Kiskin F, Shen M, Zhang J
Stem Cell Res Ther. 2023; 14(1):228.
PMID: 37649113
PMC: 10469435.
DOI: 10.1186/s13287-023-03470-w.